The Vanguard Group 13D and 13G filings for Avanos Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 2:26 pm Sale | 2025-09-30 | 13G | Avanos Medical, Inc. AVNS | The Vanguard Group | 3,425,214 7.380% | -1,039,682 (-23.29%) | Filing |
| 2025-07-29 11:24 am Sale | 2025-06-30 | 13G | Avanos Medical, Inc. AVNS | The Vanguard Group | 4,464,896 9.650% | -953,056 (-17.59%) | Filing |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | Avanos Medical, Inc. AVNS | The Vanguard Group | 5,417,952 11.670% | -82,048 (-1.49%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Avanos Medical, Inc. AVNS | The Vanguard Group | 5,500,000 11.830% | 278,214 (+5.33%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Avanos Medical, Inc. AVNS | The Vanguard Group | 5,221,786 10.840% | 211,891 (+4.23%) | Filing |
| 2021-06-10 10:06 am Purchase | 2021-05-28 | 13G | Avanos Medical, Inc. AVNS | The Vanguard Group | 5,009,895 10.420% | 671,982 (+15.49%) | Filing |
| 2021-02-10 10:39 am Sale | 2020-12-31 | 13G | Avanos Medical, Inc. AVNS | The Vanguard Group | 4,337,913 9.070% | -202,349 (-4.46%) | Filing |